Cytokinetics Inc (NASDAQ: CYTK) stock closed at $46.16 on 2/14/25 after a major increase of 10.9%. Moreover, trading volume in this advance was exceptionally high at 341% of normal. The stock is unchanged during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Cytokinetics is currently unrated.
Rating Review
The stock is currently unrated.